These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 2428019

  • 1. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M, Rabbani SA, Goltzman D.
    Prostate; 1986; 9(2):109-15. PubMed ID: 2428019
    [Abstract] [Full Text] [Related]

  • 2. Effects of human prostatic mitogens on rat bone cells and fibroblasts.
    Koutsilieris M, Rabbani SA, Goltzman D.
    J Endocrinol; 1987 Dec; 115(3):447-54. PubMed ID: 2450942
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.
    Koutsilieris M, Rabbani SA, Bennett HP, Goltzman D.
    J Clin Invest; 1987 Oct; 80(4):941-6. PubMed ID: 2443538
    [Abstract] [Full Text] [Related]

  • 4. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS, Mohan S, Herring SJ, Baylink DJ, Linkhart TA.
    Cancer Res; 1990 Nov 01; 50(21):6902-7. PubMed ID: 1698544
    [Abstract] [Full Text] [Related]

  • 5. Heparin-binding growth factor isolated from human prostatic extracts.
    Mydlo JH, Bulbul MA, Richon VM, Heston WD, Fair WR.
    Prostate; 1988 Nov 01; 12(4):343-55. PubMed ID: 3393496
    [Abstract] [Full Text] [Related]

  • 6. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M.
    Oncol Res; 1997 Nov 01; 9(8):419-31. PubMed ID: 9436195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the pathogenesis of osteoblastic metastases by prostate cancer.
    Goltzman D, Bolivar I, Rabbani SA.
    Adv Exp Med Biol; 1992 Nov 01; 324():165-71. PubMed ID: 1283497
    [No Abstract] [Full Text] [Related]

  • 11. Mitogenic factor in human prostate extracts.
    Jacobs SC, Lawson RK.
    Urology; 1980 Nov 01; 16(5):488-91. PubMed ID: 6969486
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors.
    Dahlberg E, Snochowski M, Gustafsson JA.
    Prostate; 1980 Nov 01; 1(1):61-70. PubMed ID: 6169071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lactoferrin in human prostate tissue.
    van Sande M, Van Camp K.
    Urol Res; 1981 Nov 01; 9(5):241-4. PubMed ID: 6171084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma.
    Mydlo JH, Michaeli J, Heston WD, Fair WR.
    Prostate; 1988 Nov 01; 13(3):241-7. PubMed ID: 2463616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.